Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

castrate-sensitive prostate cancer

(KAS-trayt-SEN-sih-tiv PROS-tayt KAN-ser)
Prostate cancer that needs androgens (male hormones) to grow and therefore stops growing when androgens are not present. Many early-stage prostate cancers are androgen-dependent, so reducing the amount of androgens in the body or blocking their action may be an effective type of therapy. Also called androgen-dependent prostate cancer, androgen-sensitive prostate cancer, CSPC, hormone-sensitive prostate cancer, and HSPC.
More Information
Search NCI's Dictionary of Cancer Terms